Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Lysosomal neuraminidase is the key enzyme for the intralysosomal catabolism of sialylated glycoconjugates and is deficient in two neurodegenerative lysosomal disorders, sialidosis and galactosialidosis. Here we report the identification of eight novel mutations in the neuraminidase gene of 11 sialidosis patients with various degrees of disease penetrance. Comparison of the primary structure of human neuraminidase with the primary and tertiary structures of bacterial sialidases indicated that most of the single amino acid substitutions occurred in functional motifs or conserved residues. On the basis of the subcellular distribution and residual catalytic activity of the mutant neuraminidases we assigned the mutant proteins to three groups: (i) catalytically inactive and not lysosomal; (ii) catalytically inactive, but localized in lysosome; and (iii) catalytically active and lysosomal. In general, there was a close correlation between the residual activity of the mutant enzymes and the clinical severity of disease. Patients with the severe infantile type II disease had mutations from group I, whereas patients with a mild form of type I disease had at least one mutation from group III. Mutations from the second group were mainly found in juvenile type II patients with intermediate clinical severity. Overall, our findings explain the clinical heterogeneity observed in sialidosis and may help in the assignment of existing or new allelic combinations to specific phenotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in agreement with endogenous CTSA levels being rate-limiting for NEU1 activity (56, 81–82).”
From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [81]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
[71] Use of eukaryotic expression technology in the functional analysis of cloned genes
Cullen, B. R. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52074-2 · Cited by 822
Sialidosis: a review of human neuraminidase deficiency.
Lowden, J. A., & O′Brien, J. S. (1979) · Europe PMC (PubMed Central) · Cited by 319
Bonten, E., van der Spoel, A., Fornerod, M., Grosveld, G., & d'Azzo, A. (1996) · Genes & Development · doi:10.1101/gad.10.24.3156 · Cited by 313
Self-citation(1995) · Springer eBooks · doi:10.1007/978-1-4757-9504-2 · Cited by 302
Crennell, S. J., Garman, E. F., Laver, W. G., Vimr, E. R., & Taylor, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9852 · Cited by 228
Galjart, N. J., Gillemans, N., Harris, A., van der Horst, G. T. J., Verheijen, F. W., Galjaard, H., & d'Azzo, A. (1988) · Cell · doi:10.1016/s0092-8674(88)90999-3 · Cited by 220
Gaskell, A., Crennell, S., & Taylor, G. (1995) · Structure · doi:10.1016/s0969-2126(01)00255-6 · Cited by 215
Pshezhetsky, A. V., Richard, C., Michaud, L., Igdoura, S., Wang, S., Elsliger, M.-A., Qu, J., Leclerc, D., Gravel, R., Dallaire, L., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-316 · Cited by 212
Crennell, S., Garman, E., Laver, G., Vimr, E., & Taylor, G. (1994) · Structure · doi:10.1016/s0969-2126(00)00053-8 · Cited by 205
Miyagi, T., Wada, T., Iwamatsu, A., Hata, K., Yoshikawa, Y., Tokuyama, S., & Sawada, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5004 · Cited by 182
Conserved sequences in bacterial and viral sialidases
Roggentin, P., Rothe, B., Kaper, J. B., Galen, J., Lawrisuk, L., Vimr, E. R., & Schauer, R. (1989) · Glycoconjugate Journal · doi:10.1007/bf01047853 · Cited by 178
Fornerod, M. W. J., Boer, J. M., van Baal, S., Jaegle, M., Lindern, M. V., Murti, K. G., Davis, D. S., Bonten, J., Buijs, A., & Grosveld, G. C. (1995) · PubMed · Cited by 158
Cloning, Expression, and Chromosomal Mapping of a Human Ganglioside Sialidase
Wada, T., Yoshikawa, Y., Tokuyama, S., Kuwabara, M., Akita, H. D., & Miyagi, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0973 · Cited by 158
VERHEIJEN, F. W., PALMERI, S., HOOGEVEEN, A. T., & GALJAARD, H. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb08928.x · Cited by 139
van der Spoel, A., Bonten, E., & d'Azzo, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1588 · Cited by 137 · cited 4×
“It is well established that wild-type neuraminidase must bind to PPCA to be transported to the lysosomes and to become catalytically active (15).”
BackgroundInfluentialSelf-citationMolecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase.
Miyagi, T., Konno, K., Emori, Y., Kawasaki, H., Suzuki, K., Yasui, A., & Tsuik, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74333-6 · Cited by 120
Cloning and Characterization of NEU2, a Human Gene Homologous to Rodent Soluble Sialidases
Monti, E., Preti, A., Rossi, E. G., Ballabio, A., & Borsani, G. (1999) · Genomics · doi:10.1006/geno.1999.5749 · Cited by 118
Isolated acid neuraminidase deficiency: A distinct lysosomal storage disease
Kelly, T. E., Graetz, G. S., & Opitz, J. M. (1977) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320010105 · Cited by 101
Rudenko, G., Bonten, E., d'Azzo, A., & GJ Hol, W. (1995) · Structure · doi:10.1016/s0969-2126(01)00260-x · Cited by 97
Self-citationVerheijen, F., Brossmer, R., & Galjaard, H. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90911-1 · Cited by 95
Biochemistry and Function of Sialidases
Saito, M., & Yu, R. K. (1995) · Springer eBooks · doi:10.1007/978-1-4757-9504-2_8 · Cited by 93
Pshezhetsky, A. V., & Potier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28359 · Cited by 90
Microbial sialidases: does bigger always mean better?
Vimr, E. R. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90003-5 · Cited by 90
Crennell, S. J., Garman, E. F., Philippon, C., Vasella, A. T., Laver, G. W., Vimr, E. R., & Taylor, G. L. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0318 · Cited by 85
Lukong, K. E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1075 · Cited by 83
(1996) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1996.377.6.325 · Cited by 80
A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse
Rottier, R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.313 · Cited by 76
Ferrari, J., Harris, R., & Warner, T. G. (1994) · Glycobiology · doi:10.1093/glycob/4.3.367 · Cited by 74
Zhou, X. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.12.1977 · Cited by 67
Lysosomal Protective Protein/Cathepsin A
Bonten, E. J., Galjart, N. J., Willemsen, R., Usmany, M., Vlak, J. M., & d'Azzo, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26441 · Cited by 59
Self-citationMolecular chaperones and the heat shock response
Kaufman, R. J. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00029-8 · Cited by 42
Copurification and separation of β-galactosidase and sialidase from porcine testis
Yamamoto, Y. I., & Nishimura, K. J. (1987) · International Journal of Biochemistry · doi:10.1016/0020-711x(87)90064-4 · Cited by 41
Direct Affinity Purification and Supramolecular Organization of Human Lysosomal Cathepsin A
Pshezhetsky, A. V., & Potier, M. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1359 · Cited by 37
Rudenko, G., Bonten, E., Hol, W. G. J., & d’Azzo, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.621 · Cited by 36 · cited 1×
“The determination of the 3D structure of PPCA has already been of great value in understanding the mechanisms of maturation and catalytic activation of the enzyme and has given insight into the impact of specific mutations on the protein structure (38,39).”
BackgroundSelf-citationKelly, T. E. (1981) · American journal of diseases of children · doi:10.1001/archpedi.1981.02130320017006 · Cited by 30
Neuraminidase deficiency: case report and review of the phenotype.
Young, I. D., Young, E. P., Mossman, J., Fielder, A. R., & Moore, J. R. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.5.283 · Cited by 28
Molecular Cloning and Expression of Mouse Brain Sialidase
Fronda, C. L., Zeng, G., Gao, L., & Yu, R. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0698 · Cited by 21
Matsuo, T., Egawa, I., Okada, S., Suetsugu, M., Yamamoto, K., & Watanabe, M. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90109-0 · Cited by 13
[Saposins and sphingolipid metabolisms].
Hiraiwa, M., & Kishimoto, Y. (1996) · PubMed · Cited by 2
Cited by
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
Yogalingam, G., Bonten, E. J., van de Vlekkert, D., Hu, H., Moshiach, S., Connell, S. A., & d'Azzo, A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.005 · Cited by 185
Self-citationHinek, A., Pshezhetsky, A. V., von Itzstein, M., & Starcher, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508736200 · Cited by 176
Lysosomal multienzyme complex: Biochemistry, genetics, and molecular pathophysiology
Pshezhetsky, A. V., & Ashmarina, M. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69045-7 · Cited by 131
de Geest, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1455 · Cited by 127
“The percentage of residual neuraminidase activity in sialidosis patients’ tissues and cultured cells mostly depends on the type of mutation in the NEU1 gene, and correlates inversely with the clinical severity (12).”
Background
Metadata
- Authors
- Bonten, E. J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11-01
- Volume
- 9
- Issue
- 18
- Pages
- 2715-2725
- ISSN
- 1460-2083
- Cited by
- 132
- References
- 41
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.